Institutional investors control 3.66% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2014, these large investors purchased a net $3.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 45.1 Thousand shares of Rosetta Genomics Ltd
HIGHLANDER CAPITAL MANAGEMENT LL... Bought 38.8 Thousand shares of Rosetta Genomics Ltd